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STUDY QUESTION: Is human endometrial leucine-rich repeat-containing G-protein-coupled receptor 5 (LGR5) gene expression limited
to the postulated epithelial stem cell niche, stratum basalis glands, and is it hormonally regulated?
SUMMARY ANSWER: LGR5 expressing cells are not limited to the postulated stem cell niche but LGR5 expression is hormonally
regulated.
WHAT IS KNOWN ALREADY: The human endometrium is a highly regenerative tissue; however, endometrial epithelial stem cell mar-
kers are yet to be conﬁrmed. LGR5 is a marker of stem cells in various epithelia.
STUDY DESIGN, SIZE, DURATION: The study was conducted at a University Research Institute. Endometrial samples from 50 healthy
women undergoing benign gynaecological surgery with no endometrial pathology at the Liverpool Women’s hospital were included and ana-
lysed in the following six sub-categories; proliferative, secretory phases of menstrual cycle, postmenopausal, those using oral and local proges-
tagens and samples for in vitro explant culture.
PARTICIPANTS/MATERIALS, SETTING, METHODS: In this study, we used the gold standard method, in situ hybridisation (ISH)
along with qPCR and a systems biology approach to study the location of LGR5 gene expression in full thickness human endometrium and
Fallopian tubes. The progesterone regulation of endometrial LGR5 was examined in vivo and in short-term cultured endometrial tissue
explants in vitro. LGR5 expression was correlated with epithelial proliferation (Ki67), and expression of previously reported epithelia progeni-
tor markers (SOX9 and SSEA-1) immunohistochemistry (IHC).
MAIN RESULTS AND THE ROLE OF CHANCE: LGR5 gene expression was signiﬁcantly higher in the endometrial luminal epithelium
than in all other epithelial compartments in the healthy human endometrium, including the endometrial stratum basalis (P < 0.05). The stron-
gest SSEA-1 and SOX9 staining was observed in the stratum basalis glands, but the general trend of SOX9 and SSEA-1 expression followed
the same cyclical pattern of expression as LGR5. Stratum functionalis epithelial Ki67-LI and LGR5 expression levels correlated signiﬁcantly (r =
0.74, P = 0.01), however, they did not correlate in luminal and stratum basalis epithelium (r = 0.5 and 0.13, respectively). Endometrial LGR5
demonstrates a dynamic spatiotemporal expression pattern, suggesting hormonal regulation. Oral and local progestogens signiﬁcantly
reduced endometrial LGR5 mRNA levels compared with women not on hormonal treatment (P < 0.01). Our data were in agreement with in
silico analysis of published endometrial microarrays.
LARGE SCALE DATA:We did not generate our own large scale data but interrogated publically available large scale data sets.
LIMITATIONS, REASONS FOR CAUTION: In the absence of reliable antibodies for human LGR5 protein and validated lineage mar-
kers for the various epithelial populations that potentially exist within the endometrium, our study does not formally characterise or examine
the functional ability of the resident LGR5+ cells as multipotent.
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WIDER IMPLICATIONS OF THE FINDINGS: These data will facilitate future lineage tracing studies in the human endometrial epithe-
lium; to identify the location of stem cells and further complement the in vitro functional studies, to conﬁrm if the LGR5 expressing epithelial
cells indeed represent the epithelial stem cell population.
STUDY FUNDING/COMPETING INTEREST(S): This work was supported by funding from the Wellbeing of Women project grant
(RTF510) and Cancer Research UK (A14895). None of the authors have any conﬂicts of interest to disclose.
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Introduction
The human endometrium is a highly regenerative tissue, which under-
goes over 400 cycles of menstrual shedding and re-growth in a
woman’s life time. It is composed of two functionally distinct layers,
the superﬁcial stratum functionalis and the deeper stratum basalis.
The stratum functionalis is completely shed with menstruation and
fully regenerated within 2 weeks, up to a thickness of 16mm (Fleischer,
1999). This impressive regeneration implies that a stem cell population
may reside within the endometrial glands. The location of stem/pro-
genitor cells of the endometrium is postulated to be within the stratum
basalis, which remains after the menstrual shedding of the stratum func-
tionalis (Prianishnikov, 1978; Gargett et al., 2016).
Of the two main endometrial speciﬁc cell types, the mesenchymal
stem/progenitor cells that give rise to stromal cells are well described
and studied (Gargett et al., 2016). However, the evidence for an endo-
metrial epithelial stem cell population is sparse. Previous work suggests
that SSEA-1 and SOX9 expressing epithelial cell subpopulations have
some ability to generate gland-like structures in vitro (Valentijn et al.,
2013; Turco et al., 2017), but as yet there are no other epithelial mar-
kers with the location or functional characterisation suggestive of stem
cell speciﬁcity described in the endometrium.
Leucine-rich repeat-containing G-protein-coupled receptor 5 (LGR5)
is a transmembrane receptor (Barker et al., 2007) which belongs to a
family of glycoprotein hormone receptors (Sun et al., 2009). LGR5 is a
marker of stem cells in various epithelia such as the intestinal mucosa
(Schuijers and Clevers, 2012), gastric mucosa (Barker et al., 2010), hair
follicles (Jaks et al., 2008) and kidneys (Barker et al., 2012). In mammary
epithelium Lgr5+ cells contribute to both luminal and basal epithelia
(de Visser et al., 2012) and are essential to reconstituting mammary
glands from single cells (Plaks et al., 2013). In the intestine, LGR5 was
shown to be a Wnt target gene, regulating epithelial regeneration with a
restricted expression (visualised by in situ hybridisation (ISH)) in the intes-
tinal crypt base (Barker et al., 2007; Schuijers and Clevers, 2012). These
basal crypt cells, were previously proposed to be an adult intestinal stem
cell population, but their formal functional conﬁrmation awaited the dis-
covery of a speciﬁc marker (Leushacke and Barker, 2012). Subsequent
work on Lgr5+ cells from the intestine, using in vivo lineage tracing and a
heritable-inducible lacZ reporter gene, showed that Lgr5+ cells are long-
lived, multipotent stem cells (Gerbe et al., 2011), and a single Lgr5+ stem
cell can form organoids with a gut-like architecture containing all epithelial
cell types (Schuijers and Clevers, 2012).
LGR5 is expressed in the female reproductive organs. Lgr5 marks
stem/progenitor cells of the rodent ovary and the oviduct (Flesken-
Nikitin et al., 2013; Ng et al., 2014) where it is critical for the
maintenance of a functional corpus luteum and therefore, for success-
ful pregnancy (Sun et al., 2014). In immature and in ovarian hormone
deprived mice, Lgr5 is highly expressed in the single layer of epithelia
lining the uterine cavity and progesterone treatment down-regulated
Lgr5, suggesting an ovarian hormonal regulation (Sun et al., 2009;
Boretto et al., 2017). However, mice do not menstruate, their oes-
trous cycle is characterised by complete reabsorption of the endomet-
rial lining and therefore their epithelial regeneration pattern is
proposed to be distinct from women (Gargett et al., 2016). In the
human ovary and distal Fallopian tube (ﬁmbriae), LGR5 expression was
conﬁrmed by quantitative reverse transcription PCR (qRT-PCR)
(Ng et al., 2014), with constitutive LGR5 mRNA expression reported
in healthy human endometrial epithelium throughout the menstrual
cycle (Schuijers and Clevers, 2012; Krusche et al., 2007).
The speciﬁcity of the available anti-human-LGR5 antibodies is dis-
puted and in general, the antibody based protein expression data do not
correlate with RNA data (Munoz et al., 2012). Thus, ISH is considered
as the gold standard to detect LGR5 expressing cells in a solid tissue
(Munoz et al., 2012). Therefore in the human endometrium, antibody
based studies need further validation (Cervello et al., 2017; Gil-Sanchis
et al., 2013) to conﬁrm the exact LGR5 expressing cell population and to
elucidate the function and regulation of the LGR5 gene in those cells.
We examined the cellular localisation of LGR5 in all epithelial com-
partments of the human endometrium by ISH. As the human Fallopian
tube shares the same embryological origin and exists as a continuum
with the endometrium, we compared the expression of LGR5 in the
epithelial mucosa of the endometrium with that of the ﬁmbrial end of
the Fallopian tube (due to its known stem cell enrichment (Auersperg,
2013)) and Lgr5 expression (Ng et al., 2014). The hormone regulation
of LGR5 in the endometrium was also studied in vitro and in vivo. Finally,
published microarray datasets were interrogated to conﬁrm LGR5
expression and its progesterone regulation in the endometrium.
Materials andMethods
Human tissue
Human endometrium and tubal ﬁmbriae was obtained from 50 women
undergoing benign gynaecological surgery with no endometrial pathology
at the Liverpool Women’s hospital (Supplementary Table SI), granted
under Local Research Ethics (REC references; 09/H1005/55 and 11/
H1005/4). Informed consent was obtained from all patients.
The cycle phase of the endometrium was assigned according to the last
menstrual period and histological criteria (Noyes et al., 1975; Dallenbach-
Hellweg, 2012). Endometrium and the distal (ﬁmbrial) end of the Fallopian
tube samples were divided in to two pieces; one was ﬁxed (⩾24 h in 4%
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(v/v) buffered formalin) and parafﬁn-embedded for ISH and immunohisto-
chemical (IHC) staining, and the other immediately placed in to RNAlater
(Sigma, Dorset, UK) for RNA extraction and qRT-PCR. A further six endo-
metrial samples from the proliferative phase of the cycle were collected in
reduced serum (1%) Dulbecco’s modiﬁed Eagle’s medium (DMEM)/F12
media for short-term explant culture. ISH and IHC staining for all anti-
bodies was analysed with speciﬁc reference to the three different endo-
metrial epithelial compartments, the luminal epithelium (the single layer of
cells that forms the luminal surface or lining of the uterine cavity), the stra-
tum functionalis (glands in the upper two-thirds of the endometrium below
the luminal epithelium, surrounded by sparse stroma) and the stratum
basalis (glands in the lower one-third of the endometrium adjacent to the
endo-myometrial junction, surrounded by densely packed stroma) in full-
thickness endometrial tissue sections. Sequential sections were stained
with pancytokeratin to conﬁrm the assignment of epithelial compartment.
qRT-PCR
Total RNA from tissue samples was extracted using TRIzol Plus RNA
Puriﬁcation System (Life Technologies, Paisley, UK), and quantiﬁed by
NanoDrop ND-1000 (Thermo Fisher Scientiﬁc, Loughborough, UK). Total
RNA was reverse transcribed using AMV First Strand cDNA synthesis kit
(New England Bio Labs, Hertfordshire, UK) after DNase treatment (DNase I
(#M0303), New England Bio Labs, Hertfordshire, UK), using the manufac-
turer’s protocol as previously described (Kamal et al., 2016). cDNA was
ampliﬁed by qPCR using iTaq SYBR Green supermix (Biorad) with the Biorad
connect and the following primers: LGR5 forward (5′-CCTGCTTGACTTT
GAGGAAGACC), LGR5 reverse (5′-CCAGCCATCAAGCAGGTGTT
CA), GAPDH forward (5′-AATCCCATCACCATCTTCCA) and GAPDH
reverse (5′-TGGACTCCACGACGTACTCA). Relative transcript expres-
sion was calculated using the ΔΔCT method, normalised to the reference
gene GAPDH, using Biorad CFX manager.
ISH
ISH for LGR5 expression was performed as previously described (Baker
et al., 2015) using the RNAscope 2.5 High Deﬁnition Brown assay accord-
ing to the manufacturer’s instructions (Advanced Cell Diagnostics,
Hayward, CA) as detailed in supplementary methods. RNAscope probes
used were LGR5 (NM_003667.2, region 560–1589, catalogue number
311021), POLR2A (positive control probe, NM_000937.4, region 2514–3433,
catalogue number 310451) and dapB (negative control probe, EF191515,
region 414–862, catalogue number 310043) (Supplementary Fig. S1). LGR5
expression was quantiﬁed according to the ﬁve-grade scoring system recom-
mended by the manufacturer previously described (Baker et al., 2015) (0 =
No staining or less than 1 dot to every 10 cells (40× magniﬁcation), 1 =
1–3 dots/cell (visible at 20–40× magniﬁcation), 2 = 4–10 dots/cell, very few
dot clusters (visible at 20–40×magniﬁcation), 3 = >10 dots/cell, less than 10%
positive cells have dot clusters (visible at 20× magniﬁcation), 4 = >10 dots/
cell, more than 10% positive cells have dot clusters (visible at 20×
magniﬁcation)).
IHC
IHC was performed on sequential tissue sections according to standard
protocol as previously described (Valentijn et al., 2013). Primary antibodies
(mouse pan-monoclonal anti-cytokeratin (C2562, Sigma-Aldrich, Dorset,
UK) at 1:4000, goat polyclonal anti-SOX9 (af3075, R&D Systems,
Abingdon,UK) at 1:400, mouse monoclonal anti-Ki67 (NCL-Ki67-MM1,
Novocastra, Newcastle, UK) at 1:200, mouse monoclonal anti-SSEA-1
(125601/2, Biolegend, San Diego, CA) at 1:800 dilution) were incubated
overnight at 4°C in a humidiﬁed chamber. All slides were scanned using an
Aperio CS2 scanner (http://www.leicabiosystems.com/digital-pathology/
aperio-digital-pathology-slide-scanners/products/aperio-cs2/) and ana-
lysed using spectrum, ScanScope®.
Analysis of IHC
Percentage of nuclear Ki67 immuno-positive cells of any intensity was eval-
uated as the Ki67-labelling index (Ki67-LI) (Al Kushi et al., 2002; Kamal
et al., 2016) and the three epithelial compartments were scored separ-
ately. SOX9 and SSEA-1 immunostaining was assessed as previously
described (Valentijn et al., 2013), and detailed in Supplementary methods.
Explant culture
Endometrial explant cultures were prepared from freshly collected endo-
metrial biopsies and treated with 1 μM medroxyprogesterone acetate
(MPA) or ethanol (vehicle control) for 24 h as previously described(Valentijn
et al., 2015). Harvested tissue after treatment was washed with PBS,
immersed in RNAlater and frozen for qRT-PCR (Valentijn et al., 2015).
Systems biology
We extended our experimental data by examining all published microarray
datasets of normal, premenopausal endometrial samples from women not
on hormonal treatments to explore progesterone regulation of the LGR5
gene in the secretory compared with the proliferative menstrual cycle
phase (n = 65) (Talbi et al., 2006; Burney et al., 2007; Nguyen et al., 2012;
Sigurgeirsson et al., 2017) and in the sorted healthy normal endometrial
epithelial side population cells that enrich for the endometrial epithelial
stem cell population, against unsorted epithelial cells (Cervello et al., 2010)
(n = 8/group). The in silico methodology using oPPOSUM (http://www.
cisreg.ca/oPOSSUM/), Con Tra V3, illumina’s BaseSpace Correlation
Engine (BSCE; (Kupershmidt et al., 2010) software; https://www.illumina.
com/informatics/research/biological-data-interpretation/nextbio.html;
Illumina, San Diego, CA, USA) and Ingenuity (IPA) software programmes is
detailed in supplementary methods (Supplementary Table II–IV). (Mathew
et al., 2016; Broos et al., 2011; Kupershmidt et al., 2010; Cervello et al.,
2010; Burney et al., 2007; Talbi et al., 2006; Nguyen et al., 2012;
Sigurgeirsson et al., 2017)
Statistical methods
All statistical analyses were performed using GraphPad Prism software (Mann–
Whitney U and one-way ANOVA was used to assess differences between
groups). Spearman rank correlation was used to determine the association
between pairs of variables. The criterion for signiﬁcance was P ≤ 0.05.
Results
Healthy human premenopausal
endometrium demonstrated dynamic
spatiotemporal regulation of LGR5
expression with high LGR5 expressing cells in
the luminal and in the stratum basalis
epithelium
Full thickness whole endometrial tissue samples containing all endo-
metrial layers and cell types from the oestrogen dominant, prolifera-
tive phase of the cycle showed a trend of higher LGR5 mRNA
expression levels (as measured by qRT-PCR) compared with the sam-
ples from the progesterone dominant secretory phase of the men-
strual cycle (P = 0.5, Fig. 1A). LGR5 mRNA levels were signiﬁcantly
higher in the stem cell rich distal Fallopian tubes than in the
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Figure 1 LGR5 gene expression appears to decrease in the eutopic endometrium and Fallopian tube in the secretory phase of the menstrual cycle. (A) The
eutopic endometrial samples and fallopian tube express apparently decreased levels of LGR5 mRNA in the secretory phase of the menstrual cycle when com-
pared with the proliferative phase (n = 21). (B) Fallopian tube (at any stage of the cycle) demonstrate signiﬁcantly higher levels of LGR5 mRNA than matched
eutopic endometrium (P < 0.01) (n = 20). (C) Representative LGR5 ISH images of Fallopian tube and luminal, stratum functionalis and stratum basalis eutopic
endometrium in the proliferative and secretory stages of the menstrual cycle (All images ×1000, scale bar = 20 μm, (n = 15)). (D) Graphical representation of
semi-quantitative scoring of LGR5 ISH In the proliferative stage of the cycle, the luminal epithelium demonstrated signiﬁcantly higher LGR5 ISH staining scores
than the functionalis (P < 0.05), basalis epithelium (P < 0.01) and Fallopian tube (P < 0.02) as well as the luminal epithelium of the secretory phase (P < 0.03);
the proliferative functionalis had signiﬁcantly higher LGR5 scores than the secretory functionalis (P < 0.04); the secretory luminal epithelium showed signiﬁcantly
higher LGR5 scores than the epithelia of secretory stratum functionalis (P < 0.03), secretory stratum basalis (P < 0.05) and Fallopian tube (P < 0.02) (n = 7 per
group) (Prol = Proliferative, Sec= Secretory Funct = stratum Functionalis, Bas = stratum Basalis).
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Figure 2 Ki67-Labelling Index (Ki67-LI) correlated with endometrial epithelial cell proliferation only in the epithelial compartment of the stratum functionalis.
Epithelial LGR5 expression scores also correlated with the expression of the previously known progenitor markers SOX9 and SSEA-1 in sequential tissue sec-
tions across the cycle. (A) Representative images of Ki67, SOX9 and SSEA-1 IHC in luminal, stratum functionalis, stratum basalis epithelial compartments of the
eutopic endometrium and Fallopian tubes in the proliferative and secretory stages of the menstrual cycle (all images ×400, scale bar 10 μm). (B) Quantiﬁcation
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corresponding eutopic endometrium (P < 0.01, Fig. 1B). The cell type
expressing LGR5 was identiﬁed with ISH, demonstrating that LGR5
expression was limited to the epithelial compartment in both endo-
metrium and tube. Semi-quantitative scoring of LGR5 expression
revealed that the luminal epithelial cells expressed signiﬁcantly higher
levels of LGR5 than all other epithelial compartments in the endomet-
rium (P < 0.05, Fig. 1C and D) including the endometrial stratum basa-
lis. The reduction in LGR5 expression in the secretory phase was
conﬁrmed with ISH in the luminal (P = 0.03) and functionalis epithe-
lium (P = 0.04) respectively (Fig. 1C and D).
LGR5 expression correlated with
endometrial epithelial cell proliferation in
the stratum functionalis epithelial
compartment
The differences in the cellular proliferative activity in the three endo-
metrial epithelial compartments across the menstrual cycle were
demonstrated by the dynamic changes in the expression of the prolif-
erative marker Ki67 (Fig. 2A and B) in sequential tissue sections.
Epithelial Ki67-LI was highest in the proliferative phase with the max-
imum Ki67-LI observed in the cells of stratum functionalis glands
(median 70%, range 10–100%) and the lowest Ki67-LI seen in the stra-
tum basalis epithelium (median 30%, range 0–85%). Ki67-LI was higher
in the stratum functionalis and in luminal epithelium compared with
the stratum basalis glands in all phases of the cycle. In the secretory
phase, Ki67-LI in all epithelial compartments decreased, with the
luminal epithelial compartment demonstrating the highest Ki67-LI
(median 1%, range 0–90%) and Ki67-LI was absent in the stratum
basalis glands. Ki67-LI and LGR5 expression levels only correlated sig-
niﬁcantly (r = 0.74, P = 0.01) in the stratum functionalis epithelium.
The stratum basalis LGR5 expression persisted in the secretory phase
(Fig. 1D) while the corresponding Ki67-LI reactivity decreased signiﬁ-
cantly (P = 0.03) (Fig. 2B). The quiescent (absent Ki67-LI) atrophic
postmenopausal endometrial epithelium also expressed LGR5 (particu-
larly the luminal epithelium) (Supplementary Fig. S2).
Epithelial proliferation (Ki67-LI) in the Fallopian tube was consist-
ently very low throughout the cycle, contrasting with the dynamic tubal
LGR5 expression pattern (r = 0.23, P = 0.55).
In the human endometrium, luminal and
basalis epithelia share distinct patterns of co-
expression of LGR5 and the previously known
progenitor markers SSEA-1 and SOX9
Sequential tissue sections were employed to examine if the cellular
location of LGR5 mRNA (by ISH) was consistent with the expression
of previously described endometrial basalis progenitor markers SSEA-1
and nuclear SOX9 (by IHC, Fig. 2A). In general, SOX9 and SSEA-1
expression followed the same cyclical pattern of expression as LGR5:
levels decreased in all three endometrial epithelial compartments and
also in the tubal epithelium in the secretory phase when compared with
the samples from the proliferative phase (Fig. 2A). However, out of all
three endometrial epithelial compartments, the strongest LGR5 expres-
sion was seen in the luminal epithelium (Fig. 1C and D) whereas the
strongest SSEA-1 and SOX9 staining was observed in the stratum basalis
glands agreeing with previous reports (Valentijn et al., 2013) (Fig. 2A). It is
noteworthy that the luminal staining for both SSEA-1 and SOX9 was con-
sistently high throughout the cycle, even when their expression decreased
in the stratum functionalis epithelium in the secretory phase (Fig. 2A).
In the Fallopian tube, SOX9 staining scores and LGR5 ISH scores
were high throughout the menstrual cycle, similar to the stratum basa-
lis glands of the endometrium with only an apparent reduction in the
intensity during the secretory phase (Fig. 1D). In contrast, SSEA-1 scores
were very low in the tubal epithelium in all phases of the cycle. The co-
expression of SSEA-1 protein and LGR5 mRNA by ISH was further con-
ﬁrmed with immunoﬂuorescence staining (Supplementary Fig. S3).
Progestogens regulate LGR5 expression In
vitro and in vivo
The progestogenic regulation of LGR5 expression was examined by
treating endometrial explants in vitro with the synthetic progestogen
MPA in short-term culture and MPA treatment decreased LGR5 levels
by 1.5-fold (Fig. 3A).
The in vivo effect of progestogens on the endometrial expression of
LGR5, was tested in endometrial samples from women taking synthetic
progestogen treatment (progesterone only pill, ‘POP’, or levonorgestrel-
releasing intrauterine system, ‘LNG-IUS’) and a signiﬁcant reduction of
LGR5 mRNA levels was observed with progestogen treatment com-
pared with the normal eutopic endometrium of women not on hormo-
nal treatments (P < 0.01, Fig. 3B). Even with these very low levels, the
luminal epithelium continued to retain higher LGR5 expression than the
glands following progestogen treatment (Fig. 3C and D).
LGR5 expression did not correlate with
epithelial cell proliferation in progesterone
treated human endometrial samples
The luminal and glandular epithelial Ki67-LI was much higher in the
POP samples when compared to the LNG-IUS treated endometrium
(POP luminal median 50%, range 40–75%, glands median 70%, range
50–85%, LNG-IUS luminal median 1%, range 0–1%, glands median 2%
range 0–2%, Fig. 4A and B). Therefore, the Ki67-LI levels in the POP
treated samples did not correlate with the levels of LGR5 expression,
whereas in the atrophic glandular and luminal epithelial cells of the
LNG-IUS samples there was low levels of both LGR5 and Ki67-LI.
In silico analysis of published microarray data
revealed potential LGR5 regulating genes
conﬁrming progestagenic control
One hundred and thirty-three out of the 331 potential LGR5 regulating
transcription factors (TFs) were differentially regulated in the progesterone
of percentage Ki67-positive cells (Ki-67 LI) throughout the cycle. A minimum of 25 ﬁelds of cells were counted at ×400 magniﬁcation (n = 7 per group). The
stratum functionalis in the proliferative phase has the highest Ki67-LI and is statistically higher than the stratum functionalis epithelium in the secretory phase
(P < 0.05). Ki67-LI decreased dramatically in the secretory phase of the cycle in all epithelial compartments (Prol = Proliferative, Sec = Secretory Funct = stra-
tum Functionalis, Bas = stratum Basalis).
6 Tempest et al.
Downloaded from https://academic.oup.com/humrep/advance-article-abstract/doi/10.1093/humrep/dey083/4965833
by University of Liverpool user
on 23 May 2018
dominant secretory endometrium when compared with the proliferative
endometrium (Supplementary Tables SII and III), supporting a role for pro-
gesterone in the regulation of LGR5 expression. The LGR5 gene promoter
has high-afﬁnity binding sites for the progesterone receptor, suggesting a
direct regulation. The sorted human endometrial epithelial side population
cells (enriched for stem cells) showed differential expression of 48 TFs that
potentially regulate LGR5 compared with the unsorted differentiated epi-
thelial cells (Supplementary Table SIV). The analysis of the upstream
Figure 3 Progestagens regulate LGR5 expression In vitro and In vivo. (A) LGR5 mRNA expression levels analysed by qRT-PCR. Explants treated with MPA
(‘+MPA’) expressed lower LGR5 levels relative to GAPDH when compared with the same of vehicle-treated explants (‘−MPA’) (n = 6 per group). (B) LGR5
mRNA expression by qRT-PCR. Patients taking the oral progesterone only pill (POP) or having the levonorgestrel-releasing intrauterine system (LNG-IUS) have
signiﬁcantly less LGR5 mRNA expression relative to GAPDH when compared with normal eutopic proliferative and secretory endometrium (P < 0.01 and P <
0.04, respectively). Untreated and progesterone treated (POP/LNG-IUS) (n = 6 per group). (C) Representative LGR5 ISH images of POP treated and LNG-IUS
treated luminal and glandular eutopic endometrium (All images ×1000, scale bar = 20 μm). (D) Graphical representation of semi-quantitative scoring of LGR5 ISH.
The luminal epithelium has more LGR5 when compared with the glandular epithelium in the POP and LNG-IUS treated samples (n= 6 per group).
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regulating drugs and chemicals in IPA core analysis of the LGR5 regulating
genes that are differentially expressed in both side population epithelial
cells and in the secretory phase endometrium identiﬁed progesterone,
conﬁrming our in vitro and in vivo wet-lab data (Supplementary Fig. S4) sug-
gesting a role for progesterone in LGR5 gene expression.
Discussion
This is the ﬁrst comprehensive study employing the gold standard meth-
od; ISH, in order to examine the cellular location of LGR5 expression in
full thickness normal human endometrium. High LGR5 expressing cells
were seen in the endometrial luminal epithelium and in the stratum basa-
lis. Healthy human endometrium shows a dynamic spatiotemporal pat-
tern of LGR5 expression, suggesting hormonal regulation. Endogenous
and exogenous progestogens appear to inhibit LGR5 expression in the
endometrium both in vitro and in vivo, and these data and in silico analysis
of published endometrial microarray datasets were in agreement.
Previous evidence from other epithelial tissues proposes LGR5
expression to be limited to stem cells and thus for LGR5 to be an
epithelial stem cell marker (Kumar et al., 2014). We have shown that
LGR5 was not localised to a small number of cells in the adult endo-
metrial basalis epithelium; the proposed location of the stem cell niche
(Valentijn et al., 2013; Gargett et al., 2016). The LGR5 expression we
have seen in the human adult endometrium, unlike in the small intes-
tine, mimics the Lgr5 expression pattern seen in mouse uteri (Sun
et al., 2009). A uniform expression of Lgr5 was seen in the ovariecto-
mised uterine epithelium and it is suggested that most of these remain-
ing epithelial cells have the potential to proliferate when necessary for
uterine glandular growth (Sun et al., 2009). A mouse endometrial epi-
thelial organoid system, which allowed long-term expansion of epithe-
lium, also showed Lgr5 gene expression (Boretto et al., 2017). In
contrast, in humans, the whole of the endometrial functional layer is
regularly shed with menstruation, a phenomenon not relevant to most
mammals including rodents. The initial step of the embryo attachment
and implantation occurs at the luminal epithelium, which exists at a
relatively distant location in cellular terms from the stratum basalis (up
to 16 mm in the mid-secretory phase). Due to external assaults such
as mechanical friction or infection, cells are continually lost and
replaced from the surface of any epithelial tissue including the skin and
intestine (Barker, 2014); therefore a similar daily cellular loss is likely to
happen at the endometrial luminal epithelium which is exposed to the
uterine cavity and external environment. The daily maintenance of this
luminal epithelium may require locally positioned cells with progenitor
ability. Supporting this hypothesis, rapid Lgr5+ epithelial cell prolifer-
ation can be observed in many other organs upon tissue damage
(Beumer and Clevers, 2016; Ng et al., 2014).
We therefore hypothesise that it is possible for the human endomet-
rium to have more than one epithelial stem/progenitor cell pool; one
residing in the basalis (SSEA-1++SOX9++LGR5+) supporting the
massive regeneration of the functionalis after menstrual shedding or
parturition; while the other (LGR5++SSEA-1+SOX9+) supports the
embryo-implantation process, and maintains the luminal epithelial
cells that are likely to be lost on a daily basis (Fig. 5). This is in agreement
with the scanning electron microscopy studies of human endometrium,
the endometrial injury model of the rabbit (Ferenczy and Richart, 1974)
and neo-natal endometrial glandular development in humans (Cooke
et al., 2013). The persistent expression of the progenitor cell markers
SOX9 and SSEA-1 in the luminal epithelia, with concomitant high LGR5
expression, corroborate further with the above hypothesis (Barker and
Clevers, 2010; Valentijn et al., 2013). Future work examining the func-
tional properties of endometrial epithelial cell subpopulations that are iso-
lated from the two anatomical regions within the human endometrium,
which express either high or low LGR5, SOX9 and SSEA-1, is warranted.
The two antibody based studies examining LGR5 in the human
endometrium (Gil-Sanchis et al., 2013; Cervello et al., 2017) are in
contrast to our work, in that we do not detect LGR5 expression in the
stroma but only in the pancytokeratin expressing epithelial cells and
the observed proportion of epithelial cells expressing LGR5 exceeded
1%. It should be noted that mRNA and protein levels may not neces-
sarily correlate, and in our hands, the endometrial LGR5 protein
expression using two commercially available antibodies, demonstrated
non-speciﬁc staining (Supplementary Fig. S5). Therefore, agreeing with
the general consensus, we concluded that the reliability of antibodies
against LGR5 remains in considerable doubt.
Suppression of glandular regeneration and progenitor activity is pos-
tulated to occur within the progesterone-dominant, non-proliferative,
Figure 4 LGR5 expression did not correlate with epithelial cell pro-
liferation in progesterone treated human endometrial samples. (A)
Ki67-LI IHC data, in the progesterone only pill (POP) group, the glan-
dular and luminal epithelium showed high Ki67-LI but the
levonorgestrel-releasing intrauterine system (LNG-IUS) group endo-
metrial Ki67-LI was very low. (B) Representative Ki67 images of
luminal and glandular eutopic endometrium from patients treated
with either POP or LNG-IUS (all images ×400, scale bar = 10 μm, n =
6 per group).
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secretory functional epithelium, where the lowest LGR5 expression
levels were observed. This is in agreement with a possible high LGR5-
related stem/progenitor cell function and concurs with the in silico
study demonstrating the differential expression of many potential regu-
lators of LGR5 gene in the stem cell enriched endometrial epithelial
side population cells. Our interrogation of the published microarray
datasets, also sought further information on the effect of progesterone
on endometrial LGR5 gene expression. We identiﬁed binding sites for
progesterone, oestrogen and androgen receptors in the LGR5 gene
promoter and potential other LGR5 gene regulators were also differen-
tially expressed in the secretory phase endometrium. IPA core analysis
re-conﬁrmed the direct inﬂuence of progesterone on many of the
identiﬁed differentially expressed LGR5 regulators in the secretory
endometrium. Considering the intricate relationship between steroid
hormone receptors and their function, our experimental and in silico
analysis data thus suggest that progesterone may directly and also
indirectly regulate LGR5 via downstream target genes. Endometrial epi-
thelial differentiation, proliferative quiescence and inhibition of the
canonical Wnt pathway in the stratum functionalis layer are known
functions of progesterone (Wang et al., 2009) and they were also iden-
tiﬁed as signiﬁcant canonical pathways involving the differentially
expressed (progesterone regulated), LGR5 regulators in the secretory
phase endometrium. This suggests a possible functional involvement of
LGR5 in the secretory endometrium that requires exploration in future
studies.
In the absence of validated lineage markers for the various epithelial
populations that are likely to exist within the endometrium, we cannot
formally characterise the resident LGR5+ cells as multipotent. Lineage
tracing studies need to be completed in the human endometrial epi-
thelium to identify the location of stem cells, this will further comple-
ment the in vitro functional studies to conﬁrm if LGR5 expressing
epithelial cells indeed represent the epithelial stem cell population.
Supplementary data
Supplementary data are available at Human Reproduction online.
Acknowledgements
We are grateful for Calypso Dennis, Sarah Northey and Josephine
Drury for assistance with qPCR; Amelia Acha-Sagredo and Lakis
Liloglou for assistance with ISH; Soﬁa Makrydima for endometrial
explant cultures and John Woodward for assistance with Figure 5.
Authors’ roles
N.T. and D.K.H. conceived the study, designed and performed the
experiments, interpreted data, and wrote the ﬁrst draft of the manu-
script. N.A.W. and A.M.B. assisted with ISH experiments and revised
the manuscript critically for important intellectual content. All authors
revised and read the manuscript and approved the submitted ﬁnal
version.
Funding
This work was supported by funding from the Wellbeing of Women
fellowship grant (RTF510 N.T., N.A.W. and D.K.H.) and Cancer
Research UK (A14895, A.M.B. and N.A.W.).
Conﬂict of interest
No conﬂicts of interest.
References
Al Kushi A, Lim P, Aquino-Parsons C, Gilks CB. Markers of proliferative
activity are predictors of patient outcome for low-grade endometrioid
adenocarcinoma but not papillary serous carcinoma of endometrium.
Mod Pathol 2002;15:365–371.
Figure 5 Putative model of endometrial epithelial regeneration.
(A) The secretory phase endometrial epithelial conﬁguration; luminal
epithelia contains LGR5++SOX9+SSEA-1+ cells, functional glands
contain LGR5-SOX9-SSEA-1- epithelial cells and basalis glandular cells
with SOX9++SSEA-1++LGR5+ phenotype. (B) Luminal and func-
tional layers are shed at menstruation, luminal epithelium regenerated
from the stratum basalis epithelium (SOX9++SSEA-1++LGR5+)
after menstrual shedding, subsequently, the luminal epithelium (LGR5
++SOX9+SSEA-1+) throughout the cycle regenerates itself and pos-
sibly also contributes to the regeneration of functional glands in the
proliferative phase (LGR5+SOX9+SSEA-1+) whilst stratum basalis
glands are responsible for the regeneration of all/most of the epithelia
of the stratum functionalis in the proliferative phase.
9Endometrial expression of LGR5
Downloaded from https://academic.oup.com/humrep/advance-article-abstract/doi/10.1093/humrep/dey083/4965833
by University of Liverpool user
on 23 May 2018
Auersperg N. The stem-cell proﬁle of ovarian surface epithelium is repro-
duced in the oviductal ﬁmbriae, with increased stem-cell marker density
in distal parts of the ﬁmbriae. Int J Gynecol Pathol 2013;32:444–453.
Baker AM, Graham TA, Elia G, Wright NA, Rodriguez-Justo M.
Characterization of LGR5 stem cells in colorectal adenomas and carcin-
omas. Sci Rep 2015;5:8654.
Barker N. Adult intestinal stem cells: critical drivers of epithelial homeosta-
sis and regeneration. Nat Rev Mol Cell Biol 2014;15:19–33.
Barker N, Clevers H. Leucine-rich repeat-containing G-protein-coupled
receptors as markers of adult stem cells. Gastroenterology 2010;138:
1681–1696.
Barker N, Huch M, Kujala P, van de Wetering M, Snippert HJ, van Es JH,
Sato T, Stange DE, Begthel H, van den Born M et al. Lgr5(+ve) stem cells
drive self-renewal in the stomach and build long-lived gastric units
in vitro. Cell Stem Cell 2010;6:25–36.
Barker N, Rookmaaker MB, Kujala P, Ng A, Leushacke M, Snippert H, van
de Wetering M, Tan S, Van Es JH, Huch M et al. Lgr5(+ve) stem/pro-
genitor cells contribute to nephron formation during kidney develop-
ment. Cell Rep 2012;2:540–552.
Barker N, van Es JH, Kuipers J, Kujala P, van den Born M, Cozijnsen M,
Haegebarth A, Korving J, Begthel H, Peters PJ et al. Identiﬁcation of stem
cells in small intestine and colon by marker gene Lgr5. Nature 2007;449:
1003–1007.
Beumer J, Clevers H. Regulation and plasticity of intestinal stem cells during
homeostasis and regeneration. Development 2016;143:3639–3649.
Boretto M, Cox B, Noben M, Hendriks N, Fassbender A, Roose H, Amant
F, Timmerman D, Tomassetti C, Vanhie A et al. Development of orga-
noids from mouse and human endometrium showing endometrial epi-
thelium physiology and long-term expandability. Development 2017;144:
1775–1786.
Broos S, Hulpiau P, Galle J, Hooghe B, Van Roy F, De Bleser P. ConTra v2:
a tool to identify transcription factor binding sites across species, update
2011. Nucleic Acids Res 2011;39:W74–W78.
Burney RO, Talbi S, Hamilton AE, Vo KC, Nyegaard M, Nezhat CR,
Lessey BA, Giudice LC. Gene expression analysis of endometrium
reveals progesterone resistance and candidate susceptibility genes in
women with endometriosis. Endocrinology 2007;148:3814–3826.
Cervello I, Gil-Sanchis C, Mas A, Delgado-Rosas F, Martinez-Conejero JA,
Galan A, Martinez-Romero A, Martinez S, Navarro I, Ferro J et al.
Human endometrial side population cells exhibit genotypic, phenotypic
and functional features of somatic stem cells. PLoS One 2010;5:e10964.
Cervello I, Gil-Sanchis C, Santamaria X, Faus A, Vallve-Juanico J, Diaz-
Gimeno P, Genolet O, Pellicer A, Simon C. Leucine-rich repeat-contain-
ing G-protein-coupled receptor 5-positive cells in the endometrial stem
cell niche. Fertil Steril 2017;107:510–519 e513.
Cooke PS, Spencer TE, Bartol FF, Hayashi K. Uterine glands: development,
function and experimental model systems. Mol Hum Reprod 2013;19:
547–558.
Dallenbach-Hellweg G. Histopathology of the endometrium. New York:
Springer, 2012.
de Visser KE, Ciampricotti M, Michalak EM, Tan DW, Speksnijder EN, Hau
CS, Clevers H, Barker N, Jonkers J. Developmental stage-speciﬁc contri-
bution of LGR5(+) cells to basal and luminal epithelial lineages in the
postnatal mammary gland. J Pathol 2012;228:300–309.
Ferenczy A, Richart RM. Scanning electron microscopy of human female
genital tract. NY State J Med 1974;74:794–802.
Fleischer AC. Sonographic assessment of endometrial disorders. Semin
Ultrasound CT MR 1999;20:259–266.
Flesken-Nikitin A, Hwang CI, Cheng CY, Michurina TV, Enikolopov G,
Nikitin AY. Ovarian surface epithelium at the junction area contains a
cancer-prone stem cell niche. Nature 2013;495:241–245.
Gargett CE, Schwab KE, Deane JA. Endometrial stem/progenitor cells: the
ﬁrst 10 years. Hum Reprod Update 2016;22:137–163.
Gerbe F, van Es JH, Makrini L, Brulin B, Mellitzer G, Robine S, Romagnolo
B, Shroyer NF, Bourgaux JF, Pignodel C et al. Distinct ATOH1 and
Neurog3 requirements deﬁne tuft cells as a new secretory cell type in
the intestinal epithelium. J Cell Biol 2011;192:767–780.
Gil-Sanchis C, Cervello I, Mas A, Faus A, Pellicer A, Simon C. Leucine-rich
repeat-containing G-protein-coupled receptor 5 (Lgr5) as a putative
human endometrial stem cell marker. Mol Hum Reprod 2013;19:407–
414.
Jaks V, Barker N, Kasper M, van Es JH, Snippert HJ, Clevers H, Toftgard R.
Lgr5 marks cycling, yet long-lived, hair follicle stem cells. Nat Genet
2008;40:1291–1299.
Kamal AM, Bulmer JN, DeCruze SB, Stringfellow HF, Martin-Hirsch P,
Hapangama DK. Androgen receptors are acquired by healthy postme-
nopausal endometrial epithelium and their subsequent loss in endo-
metrial cancer is associated with poor survival. Br J Cancer 2016;114:
688–696.
Krusche CA, Kroll T, Beier HM, Classen-Linke I. Expression of leucine-rich
repeat-containing G-protein-coupled receptors in the human cyclic
endometrium. Fertil Steril 2007;87:1428–1437.
Kumar KK, Burgess AW, Gulbis JM. Structure and function of LGR5: an
enigmatic G-protein coupled receptor marking stem cells. Protein Sci
2014;23:551–565.
Kupershmidt I, Su QJ, Grewal A, Sundaresh S, Halperin I, Flynn J, Shekar
M, Wang H, Park J, Cui W et al. Ontology-based meta-analysis of glo-
bal collections of high-throughput public data. PLoS One 2010;5:
e13066.
Leushacke M, Barker N. Lgr5 and Lgr6 as markers to study adult stem cell
roles in self-renewal and cancer. Oncogene 2012;31:3009–3022.
Mathew D, Drury JA, Valentijn AJ, Vasieva O, Hapangama DK. In silico,
in vitro and in vivo analysis identiﬁes a potential role for steroid hormone
regulation of FOXD3 in endometriosis-associated genes. Hum Reprod
2016;31:345–354.
Munoz J, Stange DE, Schepers AG, van de Wetering M, Koo BK, Itzkovitz
S, Volckmann R, Kung KS, Koster J, Radulescu S et al. The Lgr5 intestinal
stem cell signature: robust expression of proposed quiescent ‘+4’ cell
markers. EMBO J 2012;31:3079–3091.
Ng A, Tan S, Singh G, Rizk P, Swathi Y, Tan TZ, Huang RY, Leushacke M,
Barker N. Lgr5 marks stem/progenitor cells in ovary and tubal epithelia.
Nat Cell Biol 2014;16:745–757.
Nguyen HP, Sprung CN, Gargett CE. Differential expression of Wnt sig-
naling molecules between pre- and postmenopausal endometrial epi-
thelial cells suggests a population of putative epithelial stem/
progenitor cells reside in the basalis layer. Endocrinology 2012;153:
2870–2883.
Noyes RW, Hertig AT, Rock J. Dating the endometrial biopsy. Am J Obstet
Gynecol 1975;122:262–263.
Plaks V, Brenot A, Lawson DA, Linnemann JR, Van Kappel EC, Wong KC,
de Sauvage F, Klein OD, Werb Z. Lgr5-expressing cells are sufﬁcient
and necessary for postnatal mammary gland organogenesis. Cell Rep
2013;3:70–78.
Prianishnikov VA. A functional model of the structure of the epithelium of
normal, hyperplastic and malignant human endometrium: a review.
Gynecol Oncol 1978;6:420–428.
Schuijers J, Clevers H. Adult mammalian stem cells: the role of Wnt, Lgr5
and R-spondins. EMBO J 2012;31:2685–2696.
Sigurgeirsson B, Amark H, Jemt A, Ujvari D, Westgren M, Lundeberg J,
Gidlof S. Comprehensive RNA sequencing of healthy human endomet-
rium at two time points of the menstrual cycle. Biol Reprod 2017;96:
24–33.
10 Tempest et al.
Downloaded from https://academic.oup.com/humrep/advance-article-abstract/doi/10.1093/humrep/dey083/4965833
by University of Liverpool user
on 23 May 2018
Sun X, Jackson L, Dey SK, Daikoku T. In pursuit of leucine-rich repeat-con-
taining G protein-coupled receptor-5 regulation and function in the
uterus. Endocrinology 2009;150:5065–5073.
Sun X, Terakawa J, Clevers H, Barker N, Daikoku T, Dey SK. Ovarian LGR5 is
critical for successful pregnancy. FASEB J 2014;28:2380–2389.
Talbi S, Hamilton AE, Vo KC, Tulac S, Overgaard MT, Dosiou C, Le Shay
N, Nezhat CN, Kempson R, Lessey BA et al. Molecular phenotyping of
human endometrium distinguishes menstrual cycle phases and under-
lying biological processes in normo-ovulatory women. Endocrinology
2006;147:1097–1121.
Turco MY, Gardner L, Hughes J, Cindrova-Davies T, Gomez MJ, Farrell L,
Hollinshead M, Marsh SGE, Brosens JJ, Critchley HO et al. Long-term,
hormone-responsive organoid cultures of human endometrium in a
chemically deﬁned medium. Nat Cell Biol 2017;19:568–577.
Valentijn AJ, Palial K, Al-Lamee H, Tempest N, Drury J, Von Zglinicki T,
Saretzki G, Murray P, Gargett CE, Hapangama DK. SSEA-1 isolates
human endometrial basal glandular epithelial cells: phenotypic and func-
tional characterization and implications in the pathogenesis of endomet-
riosis. Hum Reprod 2013;28:2695–2708.
Valentijn AJ, Saretzki G, Tempest N, Critchley HO, Hapangama DK.
Human endometrial epithelial telomerase is important for epithelial pro-
liferation and glandular formation with potential implications in endo-
metriosis. Hum Reprod 2015;30:2816–2828.
Wang Y, Haniﬁ-Moghaddam P, Hanekamp EE, Kloosterboer HJ,
Franken P, Veldscholte J, van Doorn HC, Ewing PC, Kim JJ,
Grootegoed JA et al. Progesterone inhibition of Wnt/β-catenin sig-
naling in normal endometrium and endometrial cancer. Clin Cancer
Res 2009;15:5784–5793.
11Endometrial expression of LGR5
Downloaded from https://academic.oup.com/humrep/advance-article-abstract/doi/10.1093/humrep/dey083/4965833
by University of Liverpool user
on 23 May 2018
